Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases-Reference-Cited by-同舟云学术

Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases

Published:2023-07-25 Issue:1 Volume:164 Page:191-197
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Khatri Vaseem M.,Mills Matthew N.,Oliver Daniel E.,Yu Hsiang-Hsuan Michael,Vogelbaum Michael A.,Forsyth Peter A.,Soliman Hatem H.,Han Hyo S.,Ahmed Kamran A.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11060-023-04402-7.pdf

Reference26 articles.

1. Kuksis M, Gao Y, Tran W, Hoey C, Kiss A, Komorowski AS, Dhaliwal AJ, Sahgal A, Das S, Chan KK, Jerzak KJ (2021) The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis. Neuro Oncol 23:894–904. https://doi.org/10.1093/neuonc/noaa285

2. Lin NU, Winer EP (2007) Brain metastases: the HER2 paradigm. Clin Cancer Res 13:1648–1655

3. Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, Dunn IF, Gaspar LE, Gatson NTN, Gondi V, Jordan JT, Lassman AB, Maues J, Mohile N, Redjal N, Stevens G, Sulman E, van den Bent M, Wallace HJ, Weinberg JS, Zadeh G, Schiff D (2022) Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol 40:492–516. https://doi.org/10.1200/jco.21.02314

4. Gerstner ER, Fine RL (2007) Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm. J Clin Oncol 25:2306–2312. https://doi.org/10.1200/jco.2006.10.0677

5. Bachelot T, Romieu G, Campone M, Diéras V, Cropet C, Dalenc F, Jimenez M, Le Rhun E, Pierga J-Y, Gonçalves A (2013) Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study. Lancet Oncol 14:64–71

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of HER2-Positive Breast Cancer with Brain Metastases Using Anlotinib and Trastuzumab Deruxtecan: A Case Report;International Journal of Women's Health;2024-07

2. Stereotactic Radiosurgery in the Management of Brain Metastases: A Case-Based Radiosurgery Society (RSS) Practice Guideline;Advances in Radiation Oncology;2023-11